美股市场个股详情
RXRX Recursion Pharmaceuticals
- 5.700
- -0.050-0.87%
收盘价 11/22 16:00 (美东)
- 5.800
- +0.100+1.75%
盘后 19:59 (美东)
16.34亿总市值-3701市盈率TTM
5.990最高价5.600最低价1370.24万股成交量5.780今开5.750昨收7915.93万成交额5.33%换手率亏损市盈率(静)2.87亿总股本15.74052周最高3.11市净率14.65亿流通值5.60052周最低--股息TTM2.57亿流通股42.810历史最高--股息率TTM6.78%振幅4.540历史最低5.777平均价1股每手
关于Recursion Pharmaceuticals公司
Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。 它通过整合跨生物学，化学，自动化，数据科学和工程学的技术创新来解码生物学，目的是从根本上改善患者的生活并使药物发现产业化。
公司介绍
公司代码RXRX
公司名称Recursion Pharmaceuticals
上市日期2021/04/16
发行价格18.00
成立日期2013
CEODr. Christopher Gibson, PhD
所属市场纳斯达克
员工数量500
年结日12-31
公司地址41 South Rio Grande Street
城市Salt Lake City
省份犹他州
国家美国
邮编84101
电话1-385-269-0203
董事高管
- 姓名
- 职务
- 年薪
- Dr. Christopher Gibson, PhD
- Chief Executive Officer, Director and President
- 861.32万
- Matthew Kinn
- Chief Business Officer
- --
- Dr. Najat Khan, PhD
- Director, Chief Research and Development Officer and Chief Commercial Officer
- --
- Dr. David J. Mauro, M.D.
- Chief Medical Officer
- 431.25万
- David Hallett, PhD
- Chief Scientific Officer
- --
- Ben R. Taylor
- Chief Financial Officer and President, Recursion UK
- --
- Kristen Rushton
- Chief Operating Officer
- --
- Lina Nilsson
- Senior Vice President and Head, Platform
- --
- Dr. Robert M. Hershberg, M.D.,PhD
- Chairman of the Board
- 30.27万
- Dr. Franziska Michor, PhD
- Director
- --
- Dean Y. Li, M.D.,PhD
- Independent Director
- 30.02万
- Dr. Blake Borgeson, PhD
- Independent Director
- 29.27万
- Zavain Dar, PhD
- Independent Director
- 30.77万
- Zachary Bogue, J.D.
- Independent Director
- 2.13万
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
暂无数据
